BUZZARD PHARMACEUTICALS AB
BUZZARD PHARMACEUTICALS AB
Industry:
Natural Resources
Founded:
2016-08-24
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.buzzardpharma.com
Status:
Active
Official Site Inspections
http://www.buzzardpharma.com
- Host name: 171.214.140.34.bc.googleusercontent.com
- IP address: 34.140.214.171
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Buzzard Pharmaceuticals AB"
BUZZARD PHARMACEUTICAL | Home
Buzzard Pharmaceuticals AB โข is based in Stockholm and was founded in 2016 by Urban Paulsson and Maarten de Château โข has a focus on developing drugs in oncologySee details»
Buzzard Pharmaceuticals AB - BIO CEO & Investor Conference | BIO
Feb 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Overview, News & Similar companies - ZoomInfo.com
Www.buzzardpharma.com. Revenue $21.5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. No recent news or media. Overview ; Who is Buzzard Pharmaceuticals. โฆSee details»
Buzzard Pharmaceuticals AB - Crunchbase Company Profile
Buzzard Pharmaceuticals AB is a Pharmaceutical company. There is no recent news or activity for this profile.See details»
Buzzard Pharmaceuticals AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Buzzard Pharmaceuticals AB of Stockholm, Stockholm. Get the latest business insights from Dun & โฆSee details»
Buzzard Pharmaceuticals - PitchBook
Buzzard Pharmaceuticals General Information Description. Developer of a pharmaceutical drug designed to be used for cancer treatment. The company is licensed with the rights to develop โฆSee details»
Buzzard Pharmaceuticals Ab · Skeppsbron 16, Stockholm, โฆ
BUZZARD PHARMACEUTICALS AB is an entity in Stockholm, STOCKHOLM registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The โฆSee details»
Buzzard Pharmaceuticals - Products, Competitors, Financials, โฆ
Buzzardpharma.com. Overview & Products; Financials; Founded Year 2016. Stage Other Investors | Alive. Mosaic Score. The Mosaic Score is an algorithm that measures the overall โฆSee details»
Buzzard Pharmaceuticals - SwedenBIO
Buzzard Pharmaceuticals AB is based at the Karolinska Institute Science Park in Stockholm and was founded in 2016 by Urban Paulsson and Maarten de Château. The company has acquired the rights to isunakinra from Eleven Biotherapeutics in 2017 with the intent to re-position isunakinra in cancer indications. Isunakinra is a chimeric protein binding to IL1R1See details»
Buzzard Pharmaceutical - VentureRadar
Buzzard Pharmaceuticals AB has a focus on developing drugs in oncology. It has acquired the rights to isunakinra from Eleven Biotherapeutics in 2017... ... Find out ...See details»
Buzzard Pharmaceuticals - LinkedIn
Buzzard Pharmaceuticals is a biopharmaceutical development company. We are developing Isunakinra, an IL-1 inhibitor for the treatment of cancer. Isunakinra (EBI-005) is a recombinant โฆSee details»
Buzzard Pharmaceuticals AB:Company Profile & Technical โฆ
Buzzard Pharmaceuticals AB is a company that provides Natural resource management and more. Buzzard Pharmaceuticals AB is headquartered in Sweden .See details»
Buzzard Pharmaceuticals AB - Drug pipelines, Patents ... - Patsnap
E14580 Background: Interleukin-1 is a master cytokine produced by macrophages (IL-1 ฮฒ) and released upon cell death (IL-1 ฮฑ). IL-1 upregulates other cytokines in the tumor โฆSee details»
UEI G1GAEEDJG785 - Government Data Insights
UEI - Entity Report for G1GAEEDJG785 BUZZARD PHARMACEUTICALS AB. Unique Entity Identifier (UEI) G1GAEEDJG785: Corporate and Governmental Entity Code (Cage Code)See details»
Buzzard Pharmaceutical - VentureRadar
Similar Companies: Alloy Therapeutics USA Privately Held Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines โฆSee details»
Buzzard Pharmaceuticals AB - BioCentury Company Profiles - BCIQ
Buzzard Pharmaceuticals AB - BioCentury Company Profiles for the biopharma industrySee details»
Buzzard Pharmaceuticals - Company Profile - Tracxn
Oct 31, 2024 Buzzard Pharmaceuticals - Developer of drugs for oncology. Raised funding from 1 investor. Buzzard Pharmaceuticals has 2858 competitors.See details»
Maarten de Château, M.D., Ph.D. | Springer Lab
Buzzard Pharmaceuticals, CEO and Founder Sixera Pharma, CEO. Contact Information. [email protected]See details»
BUZZARD PHARMACEUTICAL | PIPELINE
A recent study shows that the combination of antiโIL-1ฮฒ with antiโPD-1 treatment improves the outcome of 4T1 mammary carcinoma in mice; Each modality on its own has a modest effect โฆSee details»
Buzzard Pharmaceuticals AB (Buzzard Pharmaceuticals AB) - ่ฏ็ฉ โฆ
E14580 Background: Interleukin-1 is a master cytokine produced by macrophages (IL-1 ฮฒ) and released upon cell death (IL-1 ฮฑ). IL-1 upregulates other cytokines in the tumor โฆSee details»